Financhill
Back

Sage Therapeutics 10K Form

Sell
23

SAGE
Sage Therapeutics

Last Price:
5.82
Seasonality Move:
19.95%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SAGE News And Ratings

See the #1 stock for the next 7 days that we like better than SAGE

SAGE Financial Statistics

Sales & Book Value

Annual Sales: $86.46M
Cash Flow: $-82.37M
Price / Cash Flow: 0
Annual Sales: $9.02
Price / Book: 0.67

Profitability

EPS (TTM): -5.57000
Net Income (TTM): $-337.59M
Gross Margin: $84.3M
Return on Equity: -48.2%
Return on Assets: -43.07%

Sage Therapeutics Earnings Forecast

Key Sage Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 11 years for SAGE is 97.50%.
  • The Selling, General & Administrative Expenses for SAGE have been equal to 317.53% of Gross Profit Margin.
  • The Research & Development expenses have been 412.05% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 12 years have been positive in 1 years.

Sage Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SAGE
CUSIP: 78667J
Website: sagerx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 10.02
Quick Ratio: 9.67

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SAGE Technical Analysis vs Fundamental Analysis

Sell
23
Sage Therapeutics (SAGE) is a Sell

Is Sage Therapeutics a Buy or a Sell?

  • Sage Therapeutics stock is rated a Sell
    The current Sage Therapeutics [SAGE] share price is $6.05. The Score for SAGE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.